Suppr超能文献

甲状腺疾病与痴呆风险:一项全国范围内基于人群的病例对照研究。

Thyroid Disorders and Dementia Risk: A Nationwide Population-Based Case-Control Study.

机构信息

From the University of Arizona (D.R.W., J.R.W.), Tucson; Department of Neurology (H.W.), Mayo Clinic College of Medicine & Science, Rochester, MN; Department of Neurology (H.W.), Mayo Clinic Health System, Mankato, MN; Departments of Medical Research (Y.-H.C., C.-H.L.) and Otolaryngology (J.-J.W.), Taichung Veterans General Hospital; Institute of Medicine (J.-J.W.), Chung Shan Medical University, Taichung, Taiwan; Department of Family Medicine (C.-H.W.), Brown University Warren Alpert Medical School, Providence, RI; and Coastal Medical Hillside Family Medicine (C.-H.W.), Pawtucket, RI.

出版信息

Neurology. 2022 Aug 16;99(7):e679-e687. doi: 10.1212/WNL.0000000000200740. Epub 2022 Jul 6.

Abstract

BACKGROUND AND OBJECTIVES

Dementia has been gaining attention in aging societies and is estimated to affect 50 million adults globally in 2020, and 12% of the US population may develop a thyroid disorder in their lifetime. There have been limited studies investigating the correlation between thyroid disorder and dementia in the Asian population.

METHODS

Our large nationwide population-based case-control study used the Taiwanese National Health Insurance Research Database. A total of 7,843 adults with newly diagnosed dementia without a history of dementia or neurodegenerative disease between 2006 and 2013 were identified and included in our study. In addition, 7,843 adults without dementia diagnosis before the index date were age and sex-matched as controls. Diagnosis of hyperthyroidism or hypothyroidism before the diagnosis of dementia or the same index date was identified. Results were obtained from logistic regression models and adjusted for sex, age, history of hypertension, diabetes, coronary artery disease, depression, hyperlipidemia, alcohol dependence syndrome, tinnitus, hearing loss, and radioactive iodine treatment.

RESULTS

A total of 15,686 patients were included in the study. Both case and control groups were slightly predominantly female (4,066 [51.8%]). The mean (SD) age for those with dementia was 74.9 (11.3) years and for those without dementia was 74.5 (11.3) years. Among patients aged 65 years or older, a history of hypothyroidism was associated with an increased risk of being diagnosed with dementia (adjusted odds ratio [aOR] 1.81; 95% CI 1.14-2.87; = 0.011), which was an association not present in patients older than 50 years but younger than 65 years. We found that this association was most significant among patients aged 65 years or older with a history of hypothyroidism who received hypothyroidism medication (aOR 3.17; 95% CI 1.04-9.69; = 0.043).

DISCUSSION

Our large-scale case-control study found that among people aged 65 years or older, those with a history of hypothyroidism were associated with an 81% increased risk of having dementia and among those, there was a more than 3-fold increased dementia risk with thyroid conditions that required thyroid hormone replacement treatment. Future well-controlled prospective longitudinal studies should be conducted to elucidate these potential mechanisms and relationships.

CLASSIFICATION OF EVIDENCE

This study provides Class III evidence that among patients aged 65 years or older, a history of hypothyroidism was associated with an increased risk of being diagnosed with dementia.

摘要

背景与目的

痴呆症在老龄化社会中受到越来越多的关注,据估计,2020 年全球有 5000 万成年人患有痴呆症,在美国,12%的人口在其一生中可能会患上甲状腺疾病。亚洲人群中,关于甲状腺疾病与痴呆症之间的相关性的研究有限。

方法

我们的大型全国性基于人群的病例对照研究使用了台湾全民健康保险研究数据库。共纳入 2006 年至 2013 年间 7843 名新诊断为痴呆症且无痴呆症或神经退行性疾病病史的成年人,并将其纳入研究。此外,在指数日期之前,还纳入了 7843 名无痴呆症诊断的成年人作为对照组。在诊断为痴呆症或相同指数日期之前,确定了甲状腺功能亢进或甲状腺功能减退的诊断。结果来自逻辑回归模型,并根据性别、年龄、高血压、糖尿病、冠心病、抑郁、高血脂、酒精依赖综合征、耳鸣、听力损失和放射性碘治疗进行调整。

结果

共纳入 15686 例患者。病例组和对照组均以女性为主(4066 例[51.8%])。痴呆症患者的平均(SD)年龄为 74.9(11.3)岁,无痴呆症患者的平均(SD)年龄为 74.5(11.3)岁。在 65 岁及以上的患者中,有甲状腺功能减退病史与被诊断为痴呆症的风险增加相关(校正优势比[aOR]1.81;95%置信区间[CI]1.14-2.87; = 0.011),而在 50 岁及以上但 65 岁以下的患者中则没有这种相关性。我们发现,这种相关性在有甲状腺功能减退病史且接受甲状腺功能减退药物治疗的 65 岁及以上患者中最为显著(aOR 3.17;95%CI 1.04-9.69; = 0.043)。

讨论

我们的大规模病例对照研究发现,在 65 岁及以上的人群中,有甲状腺功能减退病史的人患痴呆症的风险增加 81%,而在这些患者中,需要甲状腺激素替代治疗的甲状腺疾病的痴呆症风险增加了 3 倍以上。未来应进行精心设计的前瞻性纵向研究,以阐明这些潜在的机制和关系。

证据分类

本研究提供了 III 级证据,表明在 65 岁及以上的患者中,有甲状腺功能减退病史与被诊断为痴呆症的风险增加相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验